RIAZ SYED: Open Payments
NPI 1427029727 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 39 payments from 8 companies in 2025. Trend: 2023 $1,163 · 2024 $883 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $321 |
| Teva Pharmaceuticals USA, Inc. | 11 | $203 |
| Axsome Therapeutics, Inc. | 5 | $140 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Alkermes, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: VRAYLAR, AUSTEDO XR, Auvelity, COBENFY, INGREZZA, REXULTI, ARISTADA, SPRAVATO.
Industry payments across NY — which companies pay providers there.
